Chief Science Officer

Robert W. Dubois, MD, PhD, joined the National Pharmaceutical Council in October 2010 as its Chief Science Officer. In this role, he oversees NPC’s research on policy issues related to comparative effectiveness research, as well as on how health outcomes are valued. Dr. Dubois, who is board certified in internal medicine, brings more than 25 years of experience in health services research and comparative clinical effectiveness. He has co-founded and led various health care research organizations in developing quality research with practical application. Most recently, he was the chief medical officer at Cerner LifeSciences, where he focused on comparative effectiveness and the use of an electronic health records infrastructure to implement clinical change. Prior to joining Cerner in 2001, Dr. Dubois co-founded Protocare Sciences and was its executive vice president, chief medical officer, and later its chief executive officer. Throughout his career, Dr. Dubois’ primary interest has centered on defining “what works” in health care and finding ways for that evidence to inform health care decision making. He is a recognized expert in the areas of defining best practice, disease management and appropriateness of care. He has authored more than 100 peer-reviewed articles on comparative effectiveness, evidence-based medicine, the development of practice guidelines and determining the optimal use of high-cost medical services. Dr. Dubois received his AB from Harvard College, his MD from the Johns Hopkins School of Medicine and his PhD in Health Policy from the RAND Graduate School. He is a member of the Medicare Evidence Development and Coverage Advisory Committee, on the Governance Board of the newly created CMS Multi-payer claims database project, is the Associate Editor of the Journal of Comparative Effectiveness Research, and is on the Advisory Boards of the Center for Medical Technology Policy and the Institute for Clinical and Economic Review.

None yet.